The global hospital consumables market size was valued at USD 308.6 billion in 2020 and is anticipated to grow at a compound annual growth rate (CAGR) of 10.89% from 2021 to 2028. The rising number of surgeries, increasing prevalence of chronic diseases, and growing elderly population are the key factors driving the market growth. Moreover, technological advancements in surgical procedures and rising preference for minimally/non-invasive surgeries are further contributing to market growth. Furthermore, the impact of COVID-19 across the globe is accelerating market growth. Chronic diseases, including Cardiovascular Diseases (CVDs), chronic respiratory diseases, diabetes, cancer, and mental illnesses, have become a leading cause of mortality and disability worldwide.
For instance, as projected by the American Heart Association, more than 130 million adults or 45.1% of the U.S. population might suffer from some form of CVD by 2035. Likewise, according to the CDC, about 655,000 Americans die from heart disease annually, that’s 1 in every 4 deaths. Moreover, the increasing prevalence of cancer is a high-impact-rendering driver for the market. For instance, as per the CDC report, cancer is a leading cause of death across the globe and accounted for nearly 10 million deaths in 2020. Moreover, the prevalence of cancer is estimated to increase by 70.0% in the coming years.
Therefore, the presence of a high patient pool suffering from chronic diseases leads to an increase in the number of hospital admissions. According to the Partnership to Fight Chronic Disease, Americans suffering from chronic diseases account for 81% of hospital admissions. Hence, the frequent rising prevalence of chronic diseases coupled with increasing hospital admissions are expected to lead to the growth of the market.
Aging is considered the greatest risk factor for diseases, such as cardiovascular, urological, and neurological diseases. These diseases might require surgical/diagnostic procedures, which include medical consumables, such as gloves, guidewires catheters, stethoscopes, and thermometers. Elderly people (aged ≥65 years) are currently the fastest-growing sector of the general population in the U.S. According to the U.S. Census Bureau 2017 National Population statistics, nearly 1 in 4 U.S. citizens is likely to be an older adult by 2060. As per the same source, by 2030, all baby boomers are expected to be older than 65.
Similarly, the rising geriatric population in countries, such as Japan and China, is expected to be a high-impact rendering driver for the market growth in Asia Pacific region. For instance, according to the Japan Times, in September 2021, an estimated number of people aged 65 years or older was 36.17 million. In addition, increasing sophistication in medical procedures and improved success rate owing to the rising use of advanced consumables and availability of services provided in the hospital are expected to drive the market in Asia Pacific.
The demand for Minimally Invasive Surgeries (MIS) is increasing rapidly across the globe. These procedures cause lesser trauma to patients and facilitate quicker recovery than invasive procedures, such as open-heart surgery. Research results published by manufacturers (Ethicon Endo-Surgery, Inc.) suggest that MIS are rapidly replacing open/invasive surgeries owing to the factors, such as higher patient satisfaction owing to lesser incision wounds and lesser number of postsurgical complications &lower mortality rates.
Medical consumables, such as guidewires, cannulas, and catheters, are generally used in minimally invasive procedures, thus raising demand for MIS is expected to boost the market growth during the forecast period. Moreover, these advanced surgeries are mostly performed in hospital settings, thus the increasing popularity of these surgeries and demand for consumable medical devices are expected to drive the market.
The COVID-19 outbreak and rising hospital admissions across the world have boosted product demand dramatically. Globally, as per the reports of the World Health Organization (WHO), there are around 24,55,11,935 confirmed COVID-19 cases across 195 counties, which has led to 49,80,817 deaths. As a result, hospitals have been overburdened with COVID-19 patients.
This unprecedented growth in cases has significantly increased the demand for advanced healthcare facilities and services to treat patients. According to the WHO estimates (2020), each month, a projected 89 million medical masks were required for COVID-19 response. The WHO has urged industry and governments to expand production of Personal Protective Equipment (PPE), such as medical gloves, masks, hospital gowns, goggles, face shields, respirators, and aprons, to meet the mounting global demand.
Moreover, the pandemic has created opportunities for local manufacturers. As lockdown restrictions are lifted in most of the countries, supply chains of most healthcare companies, offering consumables, are expected to work efficiently and smoothly over the forecast period. Players are adopting various plans and policies to gain a higher market share. They are partnering with relevant third-party vendors to reinforce their foothold in the market.
They have also established teams that would be working on implementing these strategies in the near future during pandemics. Companies also made provisions to increase the supply of consumables to hospitals and other healthcare facilities overburdened with COVID-19 patients. Thus, the market is expected to grow at a significant rate in the coming years.
The non-woven product segment accounted for the largest revenue share of more than 21% in 2020. The highest market penetration is owing to its increasing adoption during surgeries and checkups. Non-woven fabrics protect medical professionals from Hospital-acquired Infections (HAIs), which is expected to increase their demand in hospitals over the forecast period. Furthermore, the increasing incidence of chronic diseases and the growing geriatric population are among the factors expected to drive the demand for nonwoven disposables in hospitals across the globe.
On the basis of product, the market has been segmented into 18 key product categories comprising disposable medical gloves, IV kits, medical gauze, disposable syringes, sharps disposable containers, catheters, non-woven disposable products, surgical blades, medicine cups, cannula, guidewires, thermometer, stethoscope, glucometer strips, IV solutions, BP monitors, procedure trays and others.
The IV solutions segment is expected to grow at a CAGR of 11.2% during the forecast period. IV solutions are a mixture of vital nutrients that are used to treat electrolyte imbalances, restore fluid losses, and preserve fluid balance in IV therapy. These solutions also provide nutrition to people suffering from diabetes and other diseases.
In recent years, there has been an increase in the incidence of CVDs, gastrointestinal diseases, neurological diseases, cancer, and diabetes. For instance, according to the WHO, diarrheal illness is the second leading cause of death in children; it was responsible for the death of 370,000 children in 2019. Globally, diarrhea kills around 525,000 children aged under five years, each year. IV solutions are often recommended to administer intravenous therapy for treatment in such cases. These factors are expected to propel the segment growth during the forecast period.
Asia Pacific dominated the global market with the largest revenue share of more than 29% in 2020. Advancements in technology, increase in investments, improvements in reimbursement scenario, and rise in medical tourism are factors likely to drive the market growth. Moreover, the growing aging population coupled with the rising burden of chronic diseases is expected to boost the product demand in Asia Pacific in the coming years. For instance, as per the United Nations Sexual And Reproductive Health Agency (UNFPA) report, the aging population in the APAC region is rising at an unprecedented rate and by 2050, approximately one in four people in this region will be over 60 years, reaching close to 1.3 billion people.
In addition, it was also reported that CVDs, diabetes, and cancer are the most common diseases in this region. Furthermore,rapidly rising medical tourism and increasing demand for technologically advanced & cost-efficient healthcare solutions are likely to exhibit significant growth opportunities for the market in this region.
North America accounted for the second-largest market share owing to increased surgical procedures, favorable reimbursement policies, conducive regulatory reforms in the healthcare sector, and well-established healthcare infrastructure. For instance, according to the American Hospital Association, there were 6,090 community hospitals, 208 Federal Government hospitals, and 625 nonfederal psychiatric hospitals in the U.S. A significant increase in the number of hospitals and hospital admissions for chronic diseases is boosting the product demand, thereby, propelling the market growth. The ease of access to healthcare technologies and the presence of strong distribution channels are also among the key factors contributing to the regional market growth.
Key players are involved in adopting strategies, such as mergers & acquisitions, partnerships, and new product launches, to strengthen their foothold in the market. For instance, in February 2020, Baxter launched peri-strips dry with Veritas Collagen Matrix (PSDV), a secure grip technology. The new product will help mitigate bleeding during bariatric and other procedures. The product also received the 510(k) clearance from the U.S. Food and Drug Administration (U.S. FDA).
In May 2019, B. Braun Medical Inc., a part of the B. Braun Group of Companies, invested USD 1 billion in novel and advanced IV therapy manufacturing facilities. The aim of the strategy was to help assure a regular and reliable supply of crucial IV fluids for American health care providers, on a daily basis. Some prominent players in the global hospital consumables market include:
McKesson Medical-Surgical Inc.
Medline Industries, Inc.
B. Braun Melsungen A.G.
Terumo Medical Corp.
Owens and Minor
Smith And Nephew, Inc.
Fresenius Medical Care AG & Co. KGaA
Market size value in 2021
USD 345.99 billion
Revenue forecast in 2028
USD 713.17 billion
CAGR of 10.89% from 2021 to 2028
Base year for estimation
2016 - 2019
2021 - 2028
Revenue in USD million/billion and CAGR from 2021 to 2028
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Product and region
North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA)
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Australia; South Korea; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE
Key companies profiled
McKesson Medical-Surgical Inc.; Medline Industries, Inc.; B. Braun Melsungen A.G.; Terumo Medical Corp.; Owens and Minor; Smith and Nephew, Inc.; Cardinal Health; 3M; Baxter; Fresenius Medical Care AG & Co. KGaA
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global hospital consumables market report on the basis of product and region:
Product Outlook (Revenue, USD Million, 2016 - 2028)
Disposable Medical Gloves
Medical Gauze & Tapes
Sharps Disposable Containers
Non-woven Disposable Products
Regional Outlook (Revenue, USD Million, 2016 - 2028)
Middle East & Africa
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."